Research Article

Efficacy and Safety of Modified Yupingfeng Nasal Spray in Controlling the Recurrence of Persistent and Moderate-Severe Allergic Rhinitis: Study Protocol for a Multicenter, Open-Label, Randomized, and Parallel-Arm Trial

Table 3

Participants’ timeline of this study.


Note. w, week; w1, the first week; w2, the second week; Wx, timepoint when subjects meet the clinical control standard; drug withdrawal (wx+2), timepoint when subjects meet the clinical control standard and last for two weeks.